Invention Grant
- Patent Title: CD44v6-derived cyclic peptides for treating cancers and angiogenesis related diseases
-
Application No.: US15532817Application Date: 2015-12-07
-
Publication No.: US10703796B2Publication Date: 2020-07-07
- Inventor: Alexandra Matzke-Ogi , Véronique Orian-Rousseau , Uwe Haberkorn , Thomas Lindner , Walter Mier
- Applicant: AMCURE GMBH
- Applicant Address: DE Eggenstein-Leopoldshafen DE Heidelberg
- Assignee: AMCURE GMBH,RUPRECHT-KARLS-UNIVERSITÄT
- Current Assignee: AMCURE GMBH,RUPRECHT-KARLS-UNIVERSITÄT
- Current Assignee Address: DE Eggenstein-Leopoldshafen DE Heidelberg
- Agency: Fenwick & West LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@5695d4b9
- International Application: PCT/EP2015/078892 WO 20151207
- International Announcement: WO2016/087680 WO 20160609
- Main IPC: C07K14/705
- IPC: C07K14/705 ; A61K38/17 ; A61P35/00 ; A61K9/00 ; A61K45/06 ; A61K38/00
Abstract:
The present invention relates to compounds, pharmaceutical compositions and methods for treating different forms of cancer and angiogenesis related diseases using cyclic peptides.
Public/Granted literature
- US20170320930A1 CD44V6-DERIVED CYCLIC PEPTIDES FOR TREATING CANCERS AND ANGIOGENESIS RELATED DISEASES Public/Granted day:2017-11-09
Information query
